A DNA vaccine as a prophylaxis for hepatitis C virus (HCV) infection. HCV specific CTL induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.

被引：0
|
作者：
Arichi, T
Saito, T
Major, ME
Shirai, M
Engelhard, VH
Feinstone, SM
Berzofsky, JA
机构：
[1] NCI, NIH, Bethesda, MD 20892 USA
[2] US FDA, Bethesda, MD 20014 USA
[3] Univ Virginia, Charlottesville, VA USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
994
引用
收藏
页码：409A / 409A
页数：1
相关论文
共 31 条
  • [1] Dna vaccine for prophylaxis of hepatitis C virus (HCV) infection: Induction of HCV specific CTLs and protection from HCV-recombinant vaccinia infection in HLA-A2.1 transgenic mouse model.
    Arichi, T
    Saito, T
    Major, ME
    Shirai, M
    Feinstone, SM
    Berzofsky, JA
    [J]. FASEB JOURNAL, 1999, 13 (04): : A634 - A634
  • [2] Application of epitope enhancement to a prophylactic DNA vaccine for hepatitis C virus (HCV) in an HLA-A2.1 transgenic mouse model: Enhanced HCV specific CTL induction and protection from HCV-recombinant vaccinia infection.
    Arichi, T
    Major, ME
    Saito, T
    Nishioka, M
    Engelhard, VH
    Feinstone, SM
    Berzolsky, JA
    [J]. HEPATOLOGY, 2000, 32 (04) : 373A - 373A
  • [3] Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model, (Retraction of vol 97, pg 297, 2000)
    Arichi, T
    Saito, T
    Major, ME
    Belyakov, IM
    Shirai, M
    Engelhard, VH
    Feinstone, SM
    Berzofsky, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) : 5943 - 5943
  • [4] RETRACTED: Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model (Retracted Article. See vol 98, pg 5943, 2001)
    Arichi, T
    Saito, T
    Major, ME
    Belyakov, IM
    Shirai, M
    Engelhard, VH
    Feinstone, SM
    Berzofsky, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (01) : 297 - 302
  • [5] DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice
    Pancholi, P
    Perkus, M
    Tricoche, N
    Liu, QY
    Prince, AM
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (01) : 382 - 390
  • [6] Protection against infection with an HCV-recombinant vaccinia virus by vaccination with an adenoviral vector enconding hepatitis C virus (HCV) NS4a protein
    Arribillaga, L
    Sarobe, P
    Gorraiz, M
    Bruna-Romero, O
    Borras-Cuesta, F
    Prieto, J
    Ruiz, J
    Lasarte, JJ
    [J]. JOURNAL OF HEPATOLOGY, 2004, 40 : 115 - 116
  • [7] Immunization with hepatitis C virus-like particles induces protection from HCV-recombinant vaccinia infection in mice.
    Lechmann, MT
    Vergalla, J
    Satoi, J
    Triyatni, M
    Baumert, TF
    Liang, JT
    [J]. HEPATOLOGY, 2000, 32 (04) : 268A - 268A
  • [8] Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus
    Arribillaga, L
    de Cerio, ALD
    Sarobe, P
    Casares, N
    Gorraiz, M
    Vales, A
    Bruna-Romero, O
    Borrás-Cuesta, F
    Paranhos-Baccala, G
    Prieto, J
    Ruiz, J
    Lasarte, JJ
    [J]. VACCINE, 2002, 21 (3-4) : 202 - 210
  • [9] Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus
    Arribillaga, L
    de Cerio, ALD
    Sarobe, P
    Casares, N
    Gorraiz, M
    Vales, A
    Bruna-Romero, O
    Borras, F
    Paranhos-Baccala, G
    Prieto, J
    Ruiz, J
    Lasarte, JJ
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 109 - 109
  • [10] RESOLUTION OF HCV CHRONIC HEPATITIS WITH IMMUNOTHERAPY USING HEPATITIS C VIRUS RECOMBINANT VACCINIA VIRUS IN PERSISTENT INFECTION MODEL MICE
    Sekiguchi, Satoshi
    Tobita, Yoshimi
    Chiyo, Tomoko
    Kimura, Kiminori
    Kohara, Michinori
    [J]. HEPATOLOGY, 2009, 50 (06) : 8A - 9A
1234